金城医药：关于子公司收到化学原料药上市申请批准通知书的公告

Core Viewpoint - Jincheng Pharmaceutical's wholly-owned subsidiary, Beijing Jincheng Tail Pharmaceutical Co., Ltd., has received approval from the National Medical Products Administration for the marketing application of the chemical raw material drug Mirabegron [1] Group 1 - The approval notification number is 2025YS00837 [1] - The drug approved is a chemical raw material named Mirabegron [1]